- Home
- INBX vs CRNT Comparison
INBX vs CRNT Comparison
Compare INBX & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- CRNT
- Stock Information
- Founded
- INBX 2010
- CRNT 1996
- Country
- INBX United States
- CRNT Israel
- Employees
- INBX N/A
- CRNT N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- INBX Health Care
- CRNT Technology
- Exchange
- INBX Nasdaq
- CRNT Nasdaq
- Market Cap
- INBX 178.5M
- CRNT 186.7M
- IPO Year
- INBX 2020
- CRNT 2000
- Fundamental
- Price
- INBX $12.96
- CRNT $2.41
- Analyst Decision
- INBX Hold
- CRNT Strong Buy
- Analyst Count
- INBX 1
- CRNT 5
- Target Price
- INBX N/A
- CRNT $5.85
- AVG Volume (30 Days)
- INBX 86.5K
- CRNT 686.5K
- Earning Date
- INBX 05-14-2025
- CRNT 05-07-2025
- Dividend Yield
- INBX N/A
- CRNT N/A
- EPS Growth
- INBX N/A
- CRNT 367.84
- EPS
- INBX 111.58
- CRNT 0.25
- Revenue
- INBX $200,000.00
- CRNT $394,344,000.00
- Revenue This Year
- INBX N/A
- CRNT $3.86
- Revenue Next Year
- INBX N/A
- CRNT $7.12
- P/E Ratio
- INBX $0.12
- CRNT $9.43
- Revenue Growth
- INBX N/A
- CRNT 11.94
- 52 Week Low
- INBX $10.80
- CRNT $1.95
- 52 Week High
- INBX $18.95
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- INBX 53.35
- CRNT 56.15
- Support Level
- INBX $12.72
- CRNT $2.23
- Resistance Level
- INBX $13.90
- CRNT $2.46
- Average True Range (ATR)
- INBX 0.67
- CRNT 0.08
- MACD
- INBX 0.06
- CRNT 0.01
- Stochastic Oscillator
- INBX 53.87
- CRNT 84.13
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.